Abstract
Chukwuma Mbaeyi, Nishant Kishore, Tasha Stehling-Ariza
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Progress toward poliomyelitis eradication — worldwide, January 2022–December 2023
10.15585/mmwr.mm7319a4 · 2024
The global polio eradication initiative: lessons learned and prospects for success
10.1016/j.vaccine.2011.10.005 · 2011
Progress toward poliomyelitis eradication — worldwide, January 2021–March 2023
10.15585/mmwr.mm7219a3 · 2023
Progress toward poliomyelitis eradication — Pakistan, January 2023–June 2024
10.15585/mmwr.mm7336a2 · 2024
Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs)
10.1080/14760584.2024.2361060 · 2024
Unresolved referenced work
Kept as external metadata until matched
Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine — worldwide, 2016
10.15585/mmwr.mm6535a3 · 2016
Update on vaccine-derived poliovirus outbreaks — worldwide, January 2023–June 2024
10.15585/mmwr.mm7341a1 · 2024
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): novel oral polio vaccine type 2 (nOPV2) experience
10.1016/j.vaccine.2022.02.050 · 2023
No additional external references are available.